| Factor Information | |
|---|---|
| Data ID | 438 |
| Factor | platelet distribution width (PDW) |
| Description | Previous studies have found that platelet activation occurs in patients with pulmonary arterial hypertension. |
| Biomarker | NA |
| Classification | E11 (physiological factor - physical sign) |
| Association | |
|---|---|
| Application | diagnosis and prognosis |
| Objective | To access if PDW and MPV correlated with mean pulmonary artery pressure. |
| p Value | <0.001 |
| Conclusion | MPV and PDW were significantly higher in patients with APAH-CHD than the control group. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 452 |
| CHD Type | NA |
| CHD Subtype | CHD with PAH |
| Reference | |
|---|---|
| PMID | 30019380 |
| Year | 2018 |
| Title | Platelet activation markers in children with congenital heart disease associated with pulmonary arterial hypertension. |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | a nested case-control study | |
| Region | Izmir,Turkey | |
| Method | Clinical and hemodynamic data were collected. | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | right heart catheterization | |
| Group | APAH-CHD(Treatment) | healthy controls(Control) |
| Number | 37 | 43 |
| Age | 16–237 months | 12–228 months |
| Gender (Male: Female) | 15:22 | 22:21 |
| Marker Level | 16.06±1.53% | 14.42±1.83% |
